Clinical Trial Update: To Evaluate the Safety and Efficacy of TQB2858 Injection to the Subjects With Recurrent/Metastatic Nasopharyngeal Cancer [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for TQB2858 in recurrent/metastatic nasopharyngeal cancer; phase 1 and phase 2 studying safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Cancer

Drugs mentioned

• TQB2858

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Recurrent / Metastatic Nasopharyngeal Cancer | Phase 1, Phase 2 | Status: UNKNOWN